Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade.

Saved in:
Bibliographic Details
Title: Systemic rewiring of dendritic cells by melanoma-secreted midkine impairs immune surveillance and response to immune checkpoint blockade.
Authors: Catena X; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Contreras-Alcalde M; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Juan-Larrea N; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Cerezo-Wallis D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Yale University School of Medicine, New Haven, CT, USA., Calvo TG; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Mucientes C; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Olmeda D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Instituto de Investigaciones Biomédicas Sols-Morreale, Madrid, Spain., Suárez J; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Oterino-Sogo S; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martínez L; Flow Cytometry Core Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Megías D; Advanced Optical Microscopy Unit, Instituto de Salud Carlos III (ISCIII), Majadahonda, Spain., Sancho D; Immunobiology Lab, Centro Nacional de Investigación Cardiovasculares (CNIC), Madrid, Spain., Tejedo C; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Frago S; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Dudziak D; Institute of Immunology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany.; Comprehensive Cancer Center Central Germany Jena/Leipzig, Jena, Germany., Seretis A; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Stoitzner P; Department of Dermatology, Venereology and Allergology, Medical University of Innsbruck, Innsbruck, Austria., Soengas MS; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. msoengas@cnio.es.
Source: Nature cancer [Nat Cancer] 2025 Apr; Vol. 6 (4), pp. 682-701. Date of Electronic Publication: 2025 Mar 28.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2662-1347
DOI:10.1038/s43018-025-00929-y